Melpomeni Fani
Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
Neubauer M, Nicolas G, Bauman A, Fani M, Nitzsche E, Afshar-Oromieh A, Forrer F, Rentsch C, Stenner-Liewen F, Templeton A, Schäfer N, Wild D, Chirindel A, all investigators on behalf of the SSNM Therapy Working Group. Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study. Eur J Nucl Med Mol Imaging 2023
Dec 1, 2023Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
Dec 1, 2023Eur J Nucl Med Mol Imaging 2023
Neubauer Moritz C, Nicolas Guillaume, Bauman Andreas, Fani Melpomeni, Nitzsche Egbert U, Afshar-Oromieh Ali, Forrer Flavio, Rentsch Cyrill A, Stenner-Liewen Frank, Templeton Arnoud J, Schäfer Niklaus G, Wild Damian, Chirindel Alin, all investigators on behalf of the SSNM Therapy Working Group
Radiopeptide imaging and therapy in Europe
Ambrosini V, Fani M, Fanti S, Forrer F, Maecke H. Radiopeptide imaging and therapy in Europe. J Nucl Med 2011; 52 Suppl 2:42S-55S.
Dec 1, 2011Radiopeptide imaging and therapy in Europe
Dec 1, 2011J Nucl Med 2011; 52 Suppl 2:42S-55S
Ambrosini Valentina, Fani Melpomeni, Fanti Stefano, Forrer Flavio, Maecke Helmut R
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors
Abiraj K, Mansi R, Tamma M, Fani M, Forrer F, Nicolas G, Cescato R, Reubi J, Maecke H. Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors. J Nucl Med 2011; 52:1970-8.
Nov 11, 2011Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors
Nov 11, 2011J Nucl Med 2011; 52:1970-8
Abiraj Keelara, Mansi Rosalba, Tamma Maria-Luisa, Fani Melpomeni, Forrer Flavio, Nicolas Guillaume, Cescato Renzo, Reubi Jean Claude, Maecke Helmut R
In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study
Forrer F, Chen J, Fani M, Powell P, Lohri A, Müller-Brand J, Moldenhauer G, Maecke H. In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study. Eur J Nucl Med Mol Imaging 2009; 36:1443-52.
Apr 7, 2009In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study
Apr 7, 2009Eur J Nucl Med Mol Imaging 2009; 36:1443-52
Forrer Flavio, Chen Jianhua, Fani Melpomeni, Powell Pia, Lohri Andreas, Müller-Brand Jan, Moldenhauer Gerhard, Maecke Helmut R